Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-005484
Filing Date
2019-08-14
Accepted
2019-08-14 08:00:25
Documents
2
Period of Report
2019-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_081419.htm 6-K 4961
2 PRESS RELEASE exh_991.htm EX-99.1 24000
  Complete submission text file 0001171843-19-005484.txt   29965
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 191022875
SIC: 2834 Pharmaceutical Preparations